Press releases
- Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting
- Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
- Fulgent Reports First Quarter 2024 Financial Results
- Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
Key statistics
On Friday, Fulgent Genetics Inc (7F0:DEU) closed at 19.10, 3.24% above its 52-week low of 18.50, set on Apr 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.60 |
---|---|
High | 19.80 |
Low | 18.70 |
Bid | 18.80 |
Offer | 19.30 |
Previous close | 19.70 |
Average volume | 78.40 |
---|---|
Shares outstanding | 29.92m |
Free float | 20.18m |
P/E (TTM) | -- |
Market cap | 617.94m USD |
EPS (TTM) | -5.57 USD |
Data delayed at least 15 minutes, as of May 31 2024.
More ▼